Clinical trial

Study of E7389 for Advanced or Metastatic Breast Cancer

NCT00965523

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2008-01-01

PhasePHASE2

Study timeline

Study start (unknown)2008-01-01Date precision: month

Registry last updated2013-08-15

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Breast Cancerunresolved

Interventions

Eribulin MesylateDRUG · verified · RxNorm: eribulin mesylate

Sponsors & collaborators

Eisai Co., Ltd.lead sponsor

Mapped research locations

NagoyaAichi-ken, Japan1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00965523 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.